Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Saiyi Biotechnology is a specialized biotechnology company located in the China Medical City (Taizhou), focusing on the development and production of molecular diagnostic reagents and instruments. The company provides a comprehensive range of products including nucleic acid extraction kits, PCR-based detection assays for human and animal pathogens, and automated laboratory equipment. Their portfolio covers critical areas such as respiratory infections, gastrointestinal diseases, and veterinary health, notably providing solutions for COVID-19 and African Swine Fever monitoring. Saiyi Biotech is recognized for its integration of R&D, manufacturing, and sales to support clinical diagnostics and public health safety. The company maintains high quality standards, holding ISO 13485 certification and various medical device registrations. It serves a diverse clientele including hospitals, CDC centers, and veterinary institutions both domestically and internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 江苏赛亿生物技术.